The βc receptor family - Structural insights and their functional implications

Cytokine

Volumn 74, Issue 2, 2015, Pages 247-258

  Broughton, Sophie E ^a   Nero, Tracy L ^a   Dhagat, Urmi ^a   Kan, Winnie L ^b   Hercus, Timothy R ^b   Tvorogov, Denis ^b   Lopez, Angel F ^b   Parker, Michael W ^a,c  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Beta common receptor; Granulocyte macrophage colony stimulating factor; Inflammation; Interleukin 3; Interleukin 5

Indexed keywords

CD123 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR ALPHA; INTERLEUKIN 13; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 5 RECEPTOR ALPHA; INTERLEUKIN 6; JANUS KINASE 2; STAT5 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CD131 ANTIGEN; CYTOKINE;

ANGIOGENESIS; ASTHMA; ASTROCYTE; BINDING SITE; BLOOD; BONE MARROW; CELL PROLIFERATION; COLORECTAL CANCER; CYTOKINE PRODUCTION; DISEASE EXACERBATION; ENZYME ACTIVATION; EOSINOPHILIC ASTHMA; HEMATOPOIESIS; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; HUMAN; HYDROGEN BOND; HYPEREOSINOPHILIC SYNDROME; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MACROPHAGE; METASTASIS; MYELOID LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; STEM CELL; ANIMAL; CHEMISTRY; IMMUNOLOGY; PROTEIN QUATERNARY STRUCTURE; STRUCTURE ACTIVITY RELATION;

ANIMALS; CYTOKINE RECEPTOR COMMON BETA SUBUNIT; CYTOKINES; HUMANS; PROTEIN STRUCTURE, QUATERNARY; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84949626705     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2015.02.005     Document Type: Review

References (105)

1. Broughton S.E., et al. The GM-CSF/IL-3/IL-5 cytokine receptor family: from ligand recognition to initiation of signaling. Immunol Rev 2012, 250(1):277-302.
2. Hercus T.R., et al. Signalling by the betac family of cytokines. Cytokine Growth Factor Rev 2013, 24(3):189-201.
3. Hercus T.R., et al. The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease. Blood 2009, 114(7):1289-1298.
4. Wang Y., et al. Tumor-derived GM-CSF promotes inflammatory colon carcinogenesis via stimulating epithelial release of VEGF. Cancer Res 2014, 74(3):716-726.
5. Gomez-Cambronero J., Horn J., Paul C.C., Baumann M.A. Granulocyte-macrophage colony-stimulating factor is a chemoattractant cytokine for human neutrophils: involvement of the ribosomal p70 S6 kinase signaling pathway. J Immunol 2003, 171(12):6846-6855.
6. Xu Y., Zhan Y., Lew A.M., Naik S.H., Kershaw M.H. Differential development of murine dendritic cells by GM-CSF versus Flt3 ligand has implications for inflammation and trafficking. J Immunol 2007, 179(11):7577-7584.
7. Dahl C., Hoffmann H.J., Saito H., Schiotz P.O. Human mast cells express receptors for IL-3, IL-5 and GM-CSF; a partial map of receptors on human mast cells cultured in vitro. Allergy 2004, 59(10):1087-1096.
8. Lopez A.F., et al. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med 1988, 167(1):219-224.
9. Tanaka T., et al. Adult-onset hereditary pulmonary alveolar proteinosis caused by a single-base deletion in CSF2RB. J Med Genet 2011, 48(3):205-209.
10. Inoue Y., et al. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. Am J Respir Crit Care Med 2008, 177(7):752-762.
11. Nishinakamura R., Miyajima A., Mee P.J., Tybulewicz V.L., Murray R. Hematopoiesis in mice lacking the entire granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 functions. Blood 1996, 88(7):2458-2464.
12. Berenbaum F., Rajzbaum G., Amor B., Toubert A. Evidence for GM-CSF receptor expression in synovial tissue. An analysis by semi-quantitative polymerase chain reaction on rheumatoid arthritis and osteoarthritis synovial biopsies. Eur Cytokine Netw 1994, 5(1):43-46.
13. Burmester G.R., Feist E., Dorner T. Emerging cell and cytokine targets in rheumatoid arthritis. Nat Rev Rheumatol 2014, 10(2):77-88.
14. Pavord I.D., et al. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet 2012, 380(9842):651-659.
15. Jordan C.T., et al. The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells. Leukemia 2000, 14(10):1777-1784.
16. Testa U., et al. Elevated expression of IL-3Ralpha in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosis. Blood 2002, 100(8):2980-2988.
17. Jin L., et al. Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells. Cell Stem Cell 2009, 5(1):31-42.
18. Busfield S.J., et al. Targeting of acute myeloid leukemia in vitro and in vivo with an anti-CD123 mAb engineered for optimal ADCC. Leukemia 2014, 28(11):2213-2221.
19. Nievergall E., et al. Monoclonal antibody targeting of IL-3 receptor alpha with CSL362 effectively depletes CML progenitor and stem cells. Blood 2014, 123(8):1218-1228.
20. Gutschalk C.M., et al. GM-CSF enhances tumor invasion by elevated MMP-2, -9, and -26 expression. Cancer Med 2013, 2(2):117-129.
21. Su S., et al. A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis. Cancer cell 2014, 25(5):605-620.
22. Nebiker C.A., et al. GM-CSF production by tumor cells is associated with improved survival in colorectal cancer. Clin Cancer Res 2014, 20(12):3094-3106.
23. Urdinguio R.G., et al. Immune-dependent and independent antitumor activity of GM-CSF aberrantly expressed by mouse and human colorectal tumors. Cancer Res 2013, 73(1):395-405.
24. Korpelainen E.I., et al. The receptor for interleukin 3 is selectively induced in human endothelial cells by tumor necrosis factor alpha and potentiates interleukin 8 secretion and neutrophil transmigration. Proc Natl Acad Sci U S A 1993, 90(23):11137-11141.
25. Korpelainen E.I., Gamble J.R., Vadas M.A., Lopez A.F. IL-3 receptor expression, regulation and function in cells of the vasculature. Immunol Cell Biol 1996, 74(1):1-7.
26. Luo X.J., et al. The interleukin 3 gene (IL3) contributes to human brain volume variation by regulating proliferation and survival of neural progenitors. PLoS One 2012, 7(11):e50375.
27. Krieger M., et al. The hematopoietic cytokine granulocyte-macrophage colony stimulating factor is important for cognitive functions. Sci Rep 2012, 2:697.
28. Lins C., Borojevic R. Interleukin-5 receptor alpha chain expression and splicing during brain development in mice. Growth Factors 2001, 19(3):145-152.
29. Awatsuji H., et al. Interleukin-4 and -5 as modulators of nerve growth factor synthesis/secretion in astrocytes. J Neurosci Res 1993, 34(5):539-545.
30. Bali B., Kovacs K.J. GABAergic control of neuropeptide gene expression in parvocellular neurons of the hypothalamic paraventricular nucleus. Eur J Neurosci 2003, 18(6):1518-1526.
31. Hansen G., et al. The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation. Cell 2008, 134(3):496-507.
32. Gearing D.P., King J.A., Gough N.M., Nicola N.A. Expression cloning of a receptor for human granulocyte-macrophage colony-stimulating factor. EMBO J 1989, 8(12):3667-3676.
33. Hayashida K., et al. Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF): reconstitution of a high-affinity GM-CSF receptor. Proc Natl Acad Sci U S A 1990, 87(24):9655-9659.
34. Patino E., et al. Structure analysis of the IL-5 ligand-receptor complex reveals a wrench-like architecture for IL-5Ralpha. Structure 2011, 19(12):1864-1875.
35. Kusano S., et al. Structural basis of interleukin-5 dimer recognition by its alpha receptor. Protein Sci 2012, 21(6):850-864.
36. Mita S., et al. Characterization of high-affinity receptors for interleukin 5 on interleukin 5-dependent cell lines. Proc Natl Acad Sci U S A 1989, 86(7):2311-2315.
37. Carr P.D., Conlan F., Ford S., Ollis D.L., Young I.G. An improved resolution structure of the human beta common receptor involved in IL-3, IL-5 and GM-CSF signalling which gives better definition of the high-affinity binding epitope. Acta Crystallogr Sect F Struct Biol Cryst Commun 2006, 62(Pt 6):509-513.
38. Rossjohn J., et al. Structure of the activation domain of the GM-CSF/IL-3/IL-5 receptor common beta-chain bound to an antagonist. Blood 2000, 95(8):2491-2498.
39. Carr P.D., et al. Crystal structure of the mouse interleukin-3 beta-receptor: insights into interleukin-3 binding and receptor activation. Biochem J 2014, 463(3):393-403.
40. Walter M.R., et al. Three-dimensional structure of recombinant human granulocyte-macrophage colony-stimulating factor. J Mol Biol 1992, 224(4):1075-1085.
41. Broughton S.E., et al. Dual mechanism of interleukin-3 receptor blockade by an anti-cancer antibody. Cell Rep 2014, 8(2):410-419.
42. Murphy J.M., et al. A novel functional epitope formed by domains 1 and 4 of the human common beta-subunit is involved in receptor activation by granulocyte macrophage colony-stimulating factor and interleukin 5. J Biol Chem 2003, 278(12):10572-10577.
43. Haman A., et al. Molecular determinants of the granulocyte-macrophage colony-stimulating factor receptor complex assembly. J Biol Chem 1999, 274(48):34155-34163.
44. Hercus T.R., et al. Identification of residues in the first and fourth helices of human granulocyte-macrophage colony-stimulating factor involved in biologic activity and in binding to the alpha- and beta-chains of its receptor. Blood 1994, 83(12):3500-3508.
45. Rajotte D., et al. Crucial role of the residue R280 at the F'-G' loop of the human granulocyte/macrophage colony-stimulating factor receptor alpha chain for ligand recognition. J Exp Med 1997, 185(11):1939-1950.
46. Wells J.A., de Vos A.M. Hematopoietic receptor complexes. Annu Rev Biochem 1996, 65:609-634.
47. Mirza S., Walker A., Chen J., Murphy J.M., Young I.G. The Ig-like domain of human GM-CSF receptor alpha plays a critical role in cytokine binding and receptor activation. Biochem J 2010, 426(3):307-317.
48. Lock P., Metcalf D., Nicola N.A. Histidine-367 of the human common beta chain of the receptor is critical for high-affinity binding of human granulocyte-macrophage colony-stimulating factor. Proc Natl Acad Sci U S A 1994, 91(1):252-256.
49. McClure B.J., et al. Molecular assembly of the ternary granulocyte-macrophage colony-stimulating factor receptor complex. Blood 2003, 101(4):1308-1315.
50. Woodcock J.M., Bagley C.J., Zacharakis B., Lopez A.F. A single tyrosine residue in the membrane-proximal domain of the granulocyte-macrophage colony-stimulating factor, interleukin (IL)-3, and IL-5 receptor common beta-chain is necessary and sufficient for high affinity binding and signaling by all three ligands. J Biol Chem 1996, 271(42):25999-26006.
51. Woodcock J.M., et al. Three residues in the common beta chain of the human GM-CSF, IL-3 and IL-5 receptors are essential for GM-CSF and IL-5 but not IL-3 high affinity binding and interact with Glu21 of GM-CSF. EMBO J 1994, 13(21):5176-5185.
52. Barry S.C., et al. Two contiguous residues in human interleukin-3, Asp21 and Glu22, selectively interact with the alpha- and beta-chains of its receptor and participate in function. J Biol Chem 1994, 269(11):8488-8492.
53. Tavernier J., et al. Structure/function analysis of human interleukin 5 and its receptor. Agents Actions Suppl 1995, 46:23-34.
54. Ramshaw H.S., et al. The Shc-binding site of the betac subunit of the GM-CSF/IL-3/IL-5 receptors is a negative regulator of hematopoiesis. Blood 2007, 110(10):3582-3590.
55. Broxmeyer H.E., et al. Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis. Nat Med 2012, 18(12):1786-1796.
56. Feng Y., Klein B.K., McWherter C.A. Three-dimensional solution structure and backbone dynamics of a variant of human interleukin-3. J Mol Biol 1996, 259(3):524-541.
57. Dey R., Ji K., Liu Z., Chen L. A cytokine-cytokine interaction in the assembly of higher-order structure and activation of the interleukine-3:receptor complex. PLoS One 2009, 4(4):e5188.
58. Barry S.C., et al. Roles of the N and C terminal domains of the interleukin-3 receptor alpha chain in receptor function. Blood 1997, 89(3):842-852.
59. Chen J., et al. A new isoform of interleukin-3 receptor alpha with novel differentiation activity and high affinity binding mode. J Biol Chem 2009, 284(9):5763-5773.
60. Milburn M.V., et al. A novel dimer configuration revealed by the crystal structure at 2.4 A resolution of human interleukin-5. Nature 1993, 363(6425):172-176.
61. Johanson K., et al. Binding interactions of human interleukin 5 with its receptor alpha subunit. Large scale production, structural, and functional studies of Drosophila-expressed recombinant proteins. J Biol Chem 1995, 270(16):9459-9471.
62. Morton T.A., et al. Analysis of the interaction between human interleukin-5 and the soluble domain of its receptor using a surface plasmon resonance biosensor. J Mol Recognit 1994, 7(1):47-55.
63. LaPorte S.L., et al. Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system. Cell 2008, 132(2):259-272.
64. Lupardus P.J., Birnbaum M.E., Garcia K.C. Molecular basis for shared cytokine recognition revealed in the structure of an unusually high affinity complex between IL-13 and IL-13Ralpha2. Structure 2010, 18(3):332-342.
65. Ishino T., Harrington A.E., Zaks-Zilberman M., Scibek J.J., Chaiken I. Slow-dissociation effect of common signaling subunit beta c on IL5 and GM-CSF receptor assembly. Cytokine 2008, 42(2):179-190.
66. Kunimoto D.Y., Harriman G.R., Strober W. Regulation of IgA differentiation in CH12LX B cells by lymphokines. IL-4 induces membrane IgM-positive CH12LX cells to express membrane IgA and IL-5 induces membrane IgA-positive CH12LX cells to secrete IgA. J Immunol 1988, 141(3):713-720.
67. Li J., Cook R., Chaiken I. Mutants of single chain interleukin 5 show asymmetric recruitment of receptor alpha and betac subunits. J Biol Chem 1996, 271(49):31729-31734.
68. Scibek J.J., et al. Biosensor analysis of dynamics of interleukin 5 receptor subunit beta(c) interaction with IL5:IL5R(alpha) complexes. Anal Biochem 2002, 307(2):258-265.
69. Zaks-Zilberman M., Harrington A.E., Ishino T., Chaiken I.M. Interleukin-5 receptor subunit oligomerization and rearrangement revealed by fluorescence resonance energy transfer imaging. J Biol Chem 2008, 283(19):13398-13406.
70. Ishino T., Harrington A.E., Gopi H., Chaiken I. Structure-based rationale for interleukin 5 receptor antagonism. Curr Pharm Des 2008, 14(12):1231-1239.
71. Ishino T., Pasut G., Scibek J., Chaiken I. Kinetic interaction analysis of human interleukin 5 receptor alpha mutants reveals a unique binding topology and charge distribution for cytokine recognition. J Biol Chem 2004, 279(10):9547-9556.
72. Boulanger M.J., Bankovich A.J., Kortemme T., Baker D., Garcia K.C. Convergent mechanisms for recognition of divergent cytokines by the shared signaling receptor gp130. Mol Cell 2003, 12(3):577-589.
73. Boulanger M.J., Chow D.C., Brevnova E.E., Garcia K.C. Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex. Science 2003, 300(5628):2101-2104.
74. Verstraete K., et al. Structural basis of the proinflammatory signaling complex mediated by TSLP. Nat Struct Mol Biol 2014, 21(4):375-382.
75. Ring A.M., et al. Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15. Nat Immunol 2012, 13(12):1187-1195.
76. Wang X., Rickert M., Garcia K.C. Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors. Science 2005, 310(5751):1159-1163.
77. Bagley C.J., Phillips J., Cambareri B., Vadas M.A., Lopez A.F. A discontinuous eight-amino acid epitope in human interleukin-3 binds the alpha-chain of its receptor. J Biol Chem 1996, 271(50):31922-31928.
78. Kraich M., et al. A modular interface of IL-4 allows for scalable affinity without affecting specificity for the IL-4 receptor. BMC Biol 2006, 4:13.
79. Layton J.E., et al. Interaction of granulocyte colony-stimulating factor (G-CSF) with its receptor. Evidence that Glu19 of G-CSF interacts with Arg288 of the receptor. J Biol Chem 1999, 274(25):17445-17451.
80. Zhang J.L., Simeonowa I., Wang Y., Sebald W. The high-affinity interaction of human IL-4 and the receptor alpha chain is constituted by two independent binding clusters. J Mol Biol 2002, 315(3):399-407.
81. Savino R., et al. Rational design of a receptor super-antagonist of human interleukin-6. EMBO J 1994, 13(24):5863-5870.
82. Syed R.S., et al. Efficiency of signalling through cytokine receptors depends critically on receptor orientation. Nature 1998, 395(6701):511-516.
83. de Vos A.M., Ultsch M., Kossiakoff A.A. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 1992, 255(5042):306-312.
84. Hercus T.R., et al. Specific human granulocyte-macrophage colony-stimulating factor antagonists. Proc Natl Acad Sci U S A 1994, 91(13):5838-5842.
85. Tavernier J., et al. Identification of receptor-binding domains on human interleukin 5 and design of an interleukin 5-derived receptor antagonist. Proc Natl Acad Sci U S A 1995, 92(11):5194-5198.
86. Kitamura T., Sato N., Arai K., Miyajima A. Expression cloning of the human IL-3 receptor cDNA reveals a shared beta subunit for the human IL-3 and GM-CSF receptors. Cell 1991, 66(6):1165-1174.
87. Tavernier J., et al. A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific alpha chain and a beta chain shared with the receptor for GM-CSF. Cell 1991, 66(6):1175-1184.
88. Miyajima A., Hara T., Kitamura T. Common subunits of cytokine receptors and the functional redundancy of cytokines. Trends Biochem Sci 1992, 17(10):378-382.
89. Baumgartner J.W., Wells C.A., Chen C.M., Waters M.J. The role of the WSXWS equivalent motif in growth hormone receptor function. J Biol Chem 1994, 269(46):29094-29101.
90. Bazan J.F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci U S A 1990, 87(18):6934-6938.
91. Kernebeck T., et al. The signal transducer gp130: solution structure of the carboxy-terminal domain of the cytokine receptor homology region. Protein Sci 1999, 8(1):5-12.
92. Miyazaki T., Maruyama M., Yamada G., Hatakeyama M., Taniguchi T. The integrity of the conserved 'WS motif' common to IL-2 and other cytokine receptors is essential for ligand binding and signal transduction. EMBO J 1991, 10(11):3191-3197.
93. Quelle D.E., Quelle F.W., Wojchowski D.M. Mutations in the WSAWSE and cytosolic domains of the erythropoietin receptor affect signal transduction and ligand binding and internalization. Mol Cell Biol 1992, 12(10):4553-4561.
94. Rozakis-Adcock M., Kelly P.A. Identification of ligand binding determinants of the prolactin receptor. J Biol Chem 1992, 267(11):7428-7433.
95. Dagil R., et al. The WSXWS motif in cytokine receptors is a molecular switch involved in receptor activation: insight from structures of the prolactin receptor. Structure 2012, 20(2):270-282.
96. Jenkins B.J., D'Andrea R., Gonda T.J. Activating point mutations in the common beta subunit of the human GM-CSF, IL-3 and IL-5 receptors suggest the involvement of beta subunit dimerization and cell type-specific molecules in signalling. EMBO J 1995, 14(17):4276-4287.
97. Jenkins B.J., Bagley C.J., Woodcock J., Lopez A.F., Gonda T.J. Interacting residues in the extracellular region of the common beta subunit of the human granulocyte-macrophage colony-stimulating factor, interleukin (IL)-3, and IL-5 receptors involved in constitutive activation. J Biol Chem 1996, 271(47):29707-29714.
98. Fuh G., et al. Rational design of potent antagonists to the human growth hormone receptor. Science 1992, 256(5064):1677-1680.
99. Rowlinson S.W., et al. Activation of chimeric and full-length growth hormone receptors by growth hormone receptor monoclonal antibodies. A specific conformational change may be required for full-length receptor signaling. J Biol Chem 1998, 273(9):5307-5314.
100. Brown R.J., et al. Model for growth hormone receptor activation based on subunit rotation within a receptor dimer. Nat Struct Mol Biol 2005, 12(9):814-821.
101. Brooks A.J., et al. Mechanism of activation of protein kinase JAK2 by the growth hormone receptor. Science 2014, 344(6185):1249783.
102. Burgess A.W., Camakaris J., Metcalf D. Purification and properties of colony-stimulating factor from mouse lung-conditioned medium. J Biol Chem 1977, 252(6):1998-2003.
103. Ihle J.N., Pepersack L., Rebar L. Regulation of T cell differentiation: in vitro induction of 20 alpha-hydroxysteroid dehydrogenase in splenic lymphocytes from athymic mice by a unique lymphokine. J Immunol 1981, 126(6):2184-2189.
104. Takatsu K., Tominaga A., Hamaoka T. Antigen-induced T cell-replacing factor (TRF). I. Functional characterization of a TRF-producing helper T cell subset and genetic studies on TRF production. J Immunol 1980, 124(5):2414-2422.
105. Carr P.D., et al. Structure of the complete extracellular domain of the common beta subunit of the human GM-CSF, IL-3, and IL-5 receptors reveals a novel dimer configuration. Cell 2001, 104(2):291-300.